CTCBIO Inc - Asset Resilience Ratio

Latest as of March 2025: 0.00%

CTCBIO Inc (060590) has an Asset Resilience Ratio of 0.00% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See CTCBIO Inc (060590) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩80.00
≈ $0.05 USD Cash + Short-term Investments

Total Assets

₩148.81 Billion
≈ $100.85 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2011–2024)

This chart shows how CTCBIO Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is CTCBIO Inc's balance sheet.

Liquid Assets Composition Over Time

This chart breaks down CTCBIO Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore CTCBIO Inc (060590) investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩80.00 0.0%
Short-term Investments ₩0.00 0%
Total Liquid Assets ₩80.00 0.00%

Asset Resilience Insights

  • Limited Liquidity: CTCBIO Inc maintains only 0.00% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

CTCBIO Inc Industry Peers by Asset Resilience Ratio

Compare CTCBIO Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
ALK-Abelló A/S
CO:ALK-B
Biotechnology 0.98%
Mirum Pharmaceuticals Inc
NASDAQ:MIRM
Biotechnology 6.89%
Xiamen Amoytop Biotech Co Ltd
SHG:688278
Biotechnology 4.69%
BB Biotech AG
SW:BION
Biotechnology 92.97%
Soleno Therapeutics Inc
NASDAQ:SLNO
Biotechnology 20.15%
Nanobiotix
NASDAQ:NBTX
Biotechnology 4.71%
Wuhan Keqian Biology Co Ltd
SHG:688526
Biotechnology 19.42%
Beijing Konruns Pharmaceutical Co Ltd
SHG:603590
Biotechnology 10.55%

Annual Asset Resilience Ratio for CTCBIO Inc (2011–2024)

The table below shows the annual Asset Resilience Ratio data for CTCBIO Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.00% ₩370.00
≈ $0.25
₩153.69 Billion
≈ $104.15 Million
-0.03pp
2023-12-31 0.03% ₩50.00 Million
≈ $33.88K
₩165.86 Billion
≈ $112.40 Million
-12.93pp
2022-12-31 12.96% ₩24.35 Billion
≈ $16.50 Million
₩187.90 Billion
≈ $127.34 Million
+8.41pp
2021-12-31 4.55% ₩7.65 Billion
≈ $5.19 Million
₩168.23 Billion
≈ $114.00 Million
-3.71pp
2020-12-31 8.26% ₩14.64 Billion
≈ $9.92 Million
₩177.17 Billion
≈ $120.07 Million
-0.65pp
2019-12-31 8.91% ₩16.62 Billion
≈ $11.27 Million
₩186.50 Billion
≈ $126.39 Million
+1.60pp
2018-12-31 7.31% ₩14.02 Billion
≈ $9.50 Million
₩191.69 Billion
≈ $129.90 Million
+2.72pp
2017-12-31 4.60% ₩8.82 Billion
≈ $5.97 Million
₩191.80 Billion
≈ $129.98 Million
+1.05pp
2016-12-31 3.55% ₩6.69 Billion
≈ $4.53 Million
₩188.68 Billion
≈ $127.86 Million
+2.44pp
2015-12-31 1.11% ₩2.15 Billion
≈ $1.46 Million
₩193.61 Billion
≈ $131.21 Million
-0.77pp
2014-12-31 1.88% ₩3.04 Billion
≈ $2.06 Million
₩162.12 Billion
≈ $109.87 Million
-15.22pp
2013-12-31 17.10% ₩25.73 Billion
≈ $17.43 Million
₩150.48 Billion
≈ $101.98 Million
+14.55pp
2012-12-31 2.54% ₩3.19 Billion
≈ $2.16 Million
₩125.36 Billion
≈ $84.96 Million
+1.69pp
2011-12-31 0.86% ₩801.82 Million
≈ $543.38K
₩93.33 Billion
≈ $63.25 Million
--
pp = percentage points

About CTCBIO Inc

KQ:060590 Korea Biotechnology
Market Cap
$49.26 Million
₩72.68 Billion KRW
Market Cap Rank
#22031 Global
#1351 in Korea
Share Price
₩3040.00
Change (1 day)
-1.78%
52-Week Range
₩2700.00 - ₩7160.00
All Time High
₩18000.00
About

CTCBIO Inc. provides various pharmaceutical products in South Korea and internationally. The company offers animal and human pharmaceuticals; feed additives and ingredients; and functional food products. It also provides cardiovascular, gastrointestinal, osteoporosis, antibiotic, smoking cessation, antifungal and antiviral, antiepileptic, allergic rhinitis, dermatology and genito-urinory, allergi… Read more